Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients' therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ. |  |
|
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Boyd Peter E. | Chief People Officer | Mar 10 '26 | Sale | 4.17 | 29,814 | 124,414 | 338,509 | Mar 11 12:52 PM | | Barber Daniel | President and CEO | Mar 10 '26 | Sale | 4.17 | 180,677 | 753,965 | 1,004,753 | Mar 11 12:52 PM | | BRAENDER LORI J | Chief Legal Officer | Mar 10 '26 | Sale | 4.17 | 40,102 | 167,346 | 442,879 | Mar 11 12:52 PM | | Cioffi Melina | SVP, Regulatory Affairs | Mar 10 '26 | Sale | 4.17 | 25,311 | 105,623 | 274,867 | Mar 11 12:52 PM | | TOTH A ERNEST JR | Chief Financial Officer | Mar 10 '26 | Sale | 4.17 | 58,254 | 243,094 | 376,112 | Mar 11 12:51 PM | | Korczynski Sherry | Chief Commercial Officer | Mar 10 '26 | Sale | 4.17 | 15,741 | 65,687 | 241,117 | Mar 11 12:51 PM | | Jung Cassie | Chief Operating Officer | Mar 10 '26 | Sale | 4.17 | 45,791 | 191,086 | 274,980 | Mar 11 12:50 PM | | Carl N. Kraus | Affiliate | Nov 17 '25 | Proposed Sale | 5.39 | 53,100 | 286,209 | | Nov 17 04:39 PM | | Jung Cassie | Chief Operating Officer | Oct 15 '25 | Option Exercise | 3.10 | 25,000 | 77,568 | 308,346 | Oct 17 02:01 PM | | Jung Cassie | Chief Operating Officer | Oct 15 '25 | Sale | 7.01 | 67,575 | 473,701 | 240,771 | Oct 17 02:01 PM | | Kraus Carl N | Chief Medical Officer | Oct 15 '25 | Sale | 7.00 | 20,272 | 141,904 | 282,475 | Oct 17 02:01 PM | | Boyd Peter E. | See Remarks | Oct 15 '25 | Sale | 7.00 | 10,000 | 70,000 | 268,323 | Oct 17 02:00 PM | | Carl N. Kraus | Officer | Oct 15 '25 | Proposed Sale | 6.88 | 40,544 | 278,943 | | Oct 15 04:45 PM | | CASSIE JUNG | Officer | Oct 15 '25 | Proposed Sale | 6.88 | 67,575 | 464,916 | | Oct 15 04:34 PM | | Peter Boyd | Officer | Oct 15 '25 | Proposed Sale | 7.00 | 10,000 | 70,000 | | Oct 15 12:24 PM | | Barber Daniel | President and CEO | Sep 26 '25 | Sale | 6.03 | 91,343 | 551,191 | 923,430 | Sep 29 04:26 PM | | Boyd Peter E. | See Remarks | Sep 26 '25 | Sale | 6.30 | 10,000 | 63,000 | 278,323 | Sep 29 04:26 PM | | Peter Boyd | Officer | Sep 26 '25 | Proposed Sale | 6.30 | 10,000 | 63,000 | | Sep 29 04:05 PM | | DANIEL BARBER | Director | Sep 26 '25 | Proposed Sale | 5.26 | 91,343 | 480,464 | | Sep 26 04:32 PM | | Barber Daniel | President and CEO | Sep 19 '25 | Sale | 6.00 | 400 | 2,400 | 1,014,773 | Sep 22 05:25 PM | | DANIEL R BARBER | Officer | Sep 19 '25 | Proposed Sale | 4.94 | 400 | 1,976 | | Sep 19 04:45 PM | | Jung Cassie | Chief Operating Officer | Sep 04 '25 | Option Exercise | 1.93 | 50,000 | 96,408 | 345,526 | Sep 08 07:06 PM | | Jung Cassie | Chief Operating Officer | Sep 04 '25 | Sale | 5.00 | 62,180 | 310,900 | 283,346 | Sep 08 07:06 PM | | Boyd Peter E. | See Remarks | Sep 05 '25 | Sale | 5.30 | 15,000 | 79,500 | 288,323 | Sep 08 05:13 PM | | Boyd Peter E. | Officer | Sep 05 '25 | Proposed Sale | 5.30 | 15,000 | 79,500 | | Sep 05 10:32 AM | | CASSIE JUNG | Officer | Sep 04 '25 | Proposed Sale | 3.95 | 62,180 | 245,611 | | Sep 04 04:26 PM |
|
